Search

Author/Creator Porter, David L

3. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma. Issue 2 (24th December 2020)

Authors:
Neelapu, Sattva S; Adkins, Sherry; Ansell, Stephen M; Brody, Joshua; Cairo, Mitchell S; Friedberg, Jonathan W; Kline, Justin P; Levy, Ronald; Porter, David L; van Besien, Koen; Werner, Michael; Bishop, Michael R
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). Issue 3 (March 2019)

Authors:
Bolaños-Meade, Javier; Reshef, Ran; Fraser, Raphael; Fei, Mingwei; Abhyankar, Sunil; Al-Kadhimi, Zaid; Alousi, Amin M; Antin, Joseph H; Arai, Sally; Bickett, Kate; Chen, Yi-Bin; Damon, Lloyd E; Efebera, Yvonne A; Geller, Nancy L; Giralt, Sergio A; Hari, Parameswaran; Holtan, Shernan G; Horowitz, ...
Journal:
Lancet
Issue:
Volume 6:Issue 3(2019)
Page Start:
e132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. (4th November 2015)

Authors:
Ruella, Marco; Barrett, David M; Kenderian, Saad S; Shestova, Olga; Hofmann, Ted J; Scholler, John; Lacey, Simon F; Melenhorst, Jan J; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David A; Hunter, Christopher A; Porter, David L; June, Carl H; Grupp, Stephan A; Gill, Saar
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗